VIPpharma ApS: Financial statements 2018
CVR: 38744763
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,461,179 and a net result of DKK 228,220 compared with DKK 760 the year before. That is an increase of 17.8% compared with the year before. Equity in the 2018 report amounted to DKK 3,416,462. The solvency ratio was 84.5%.
- Gross Profit
- DKK 1,461,179
- Profit/Loss
- DKK 228,220
- Equity
- DKK 3,416,462
- Total Assets
- DKK 4,044,540
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.5 mio. | 228 t. | 3.4 mio. | - |
| 2017 | - | 1.2 mio. | 760 | 3.2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
VIPpharma ApS has published its annual report for 2017. Gross profit came to DKK 1,240,080, and the net result was DKK 760.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.